Chemistry Reference
In-Depth Information
39. Flyvbjerg A, Khatir DS, and Jensen LJ et al. The involvement of growth hormone (GH),
insulin-like growth factors (IGFs) and vascular endothelial growth factor (VEGF) in
diabetic kidney disease.
Curr Pharm Des
2004;10:3385-3394.
40. Tikellis C, Cooper ME, and Thomas MC. Role of the renin-angiotensin system in the
endocrine pancreas: Implications for the development of diabetes.
Int J Biochem Cell
Biol
2005;38:737-751.
41. Allen TJ and Jandeleit-Dahm KA. Preventing atherosclerosis with angiotensin-con-
verting enzyme inhibitors: Emphasis on diabetic atherosclerosis.
Curr Drug Targets
Cardiovasc Haematol Disord
2005;5:503-512.
42. Brady J and Hoggan R.
Dangerous Grains.
Avery-Penguin Putnam, New York, 2002.
43. Sbarbati A, Valleta E, and Bertini M et al. Gluten sensitivity and “normal” histology: Is
the intestinal mucosa really normal?
Dig Liver Dis
2003;35:768-773.
44. Carroll KK. Experimental evidence of dietary factors and hormone-dependent cancers.
Cancer Res
1975;35:3374-3383.
45. Artaud-Wild SM, Connor SL, Sexton G, and Connor WE. Differences in coronary mor-
tality can be explained by differences in cholesterol and saturated fat intakes in 40 coun-
tries but not in France and Finland. A paradox.
Circulation
1993;88:2771-2779.
46. Moss M and Freed DL. Survival trends, coronary event rates, and the MONICA
project. Monitoring trends and determinants in cardiovascular disease.
Lancet
1999;354:862-865.
47. Dahl-Jorgensen K, Joner G, and Hanssen KF. Relationship between cows' milk con-
sumption and incidence of IDDM in childhood.
Diabetes Care
1991;14:1081-1083.
48. Ganmaa D, Li XM, and Wang J. Incidence and mortality of testicular and prostatic can-
cers in relation to world dietary practices.
Int J Cancer
2002;98:262-267.
49. Leaf A and Weber PC. Cardiovascular effects of n-3 fatty acids.
N Engl J Med
1988;318:549-557.
50. Gaby AR. Adverse effects of dietary fructose.
Altern Med Rev
2005;10:294-306.
51. Baptista JAB and Carvalho RCB. Indirect determination of Amadori compounds in
milk-based products by HPLC/ELSD/UV as an index of protein detorioration.
Food Res
Int
2004;37:739-747.
52. Hostettler-Allen RL, Tappy L, and Blum JW. Insulin resistance, hyperglycemia, and
glucosuria in intensively milk-fed calves.
J Anim Sci
1994;72:160-173.
53. Malekinejad H, Scherpenisse P, and Bergwerff AA. Naturally occurring estrogens in
processed milk and in raw milk (from gestated cows).
Agric Food Chem
2006; 54:
9785-9791.
54. Reddy GK. Cross-linking in collagen by nonenzymatic glycation increases the matrix
stiffness in rabbit Achilles tendon.
Exp Diabesity Res
2004;5:143-153.
55. Ramasamy R, Vannucci SJ, and Yan SS et al. Advanced glycation end products and
RAGE: A common thread in aging, diabetes, neurodegeneration, and inflammation.
Glycobiology
2005;15:16R-28R.
56. Tsukahara H, Shibata R, and Ohta et al. High levels of urinary pentosidine, an advanced
glycation end product, in children with acute exacerbation of atopic dermatitis:
Relationship with oxidative stress.
Metabolism
2003;52:1601-1605.
57. Kurien BT, Hensley K, Bachmann M, and Scofield RH. Oxidatively modified autoanti-
gens in autoimmune diseases.
Free Radic Biol Med
2006;41:549-556.
58. Moreira PI, Smith MA, and Zhu X et al. Oxidative stress and neurodegeneration.
Ann N
Y Acad Sci
2005;1043:543-552.
